OraVital Signs United Kingdom Distribution Agreement

Posted: September 1, 2016
Edited by Dentaltown staff

TORONTO, Canada—OraVital, the Toronto-based developer of the OraVital System for the diagnosis and treatment of the oral infections that cause periodontal disease, peri-implantitis, halitosis and caries, recently signed a distribution agreement naming Stat Health Group as its exclusive sales agent in the United Kingdom. 

“We’re very excited to be working with Stat Health Group to help us expand into the United Kingdom. Together, I believe we’ll have a positive impact on controlling oral infections as well as oral-systemic health risks," said OraVital CEO Jim Hyland, DDS.

Under the terms of the agreement, Stat Health Group will be responsible for introducing UK dental practices to the OraVital System and providing them with the necessary training, marketing support and logistical management of OraVital’s biofilm test lab analysis and prescriptive antimicrobial rinses.

“By using the OraVital System, UK dental professionals can now predictably control the oral infections that cause periodontal disease, halitosis and caries in 90 percent of their affected patients in just four weeks,” said Stat Health Group CEO Stephen Judge. “Our ultimate goal is to establish the OraVital System as the new standard of care in the United Kingdom.” 
 
Views: 113
Sponsors
Townie Perks
Townie® Poll
Do you do more or less endo procedures since you started practicing?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@dentaltown.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450